Skip to main content
Clinical Trials/EUCTR2013-005017-12-NL
EUCTR2013-005017-12-NL
Active, not recruiting
Phase 1

ooking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye. - Looking in the eye of ADHD.

Parnassia Bavo Groep - PsyQ0 sites150 target enrollmentFebruary 25, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Parnassia Bavo Groep - PsyQ
Enrollment
150
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 25, 2014
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Parnassia Bavo Groep - PsyQ

Eligibility Criteria

Inclusion Criteria

  • Patient group and control group: Age 18 to 40 years old.
  • Patient group: Diagnosis of ADHD.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 150
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patient group and control group: Severe psychiatric comorbidity; substance abuse; contraindication for the intervention.
  • Control group: ADHD; use of stimulant medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials